Enhancing Solubility and Bioavailability with Nanotechnology.
| Publicado en: | Pharmaceutical Technology Vol. 49; no. 3; pp. 16 - 19 |
|---|---|
| Autor principal: | |
| Formato: | pictorial Journal Article |
| Publicado: |
MJH Life Sciences
Apr2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=184376791&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 184376791 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 15432521 4FK jtl: Pharmaceutical Technology issn: 15432521 maglogo: N pubinfo: dt: Apr2025 vid: 49 iid: 3 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 184376791 184376791 184376791 184376791 ppf: 16 ppct: 3 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Enhancing Solubility and Bioavailability with Nanotechnology. aug: au: Challener, Cynthia A. sug: subj: Drugs, Prescription Metabolism Solubility Biological Availability Nanotechnology Drugs, Prescription Pharmacokinetics United States Food and Drug Administration Chemistry, Pharmaceutical Technology, Pharmaceutical Drug Delivery Systems Drug Development pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|